摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-[(2R)-5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol | 344899-18-9

中文名称
——
中文别名
——
英文名称
(S)-[(2R)-5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol
英文别名
Quinidine;(S)-[(2R,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R)-5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol化学式
CAS
344899-18-9
化学式
C20H24N2O2
mdl
——
分子量
324.423
InChiKey
LOUPRKONTZGTKE-SMHQJORMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    495.9±40.0 °C(Predicted)
  • 密度:
    1.21±0.1 g/cm3(Predicted)
  • 物理描述:
    Crystals or white powder. (NTP, 1992)
  • 颜色/状态:
    CRYSTALS WITH 2.5 MOL WATER OF CRYSTALLIZATION; CRYSTALS FROM DILUTE ALCOHOL
  • 熔点:
    174-175 °C after drying of solvated crystals
  • 溶解度:
    In water, 140 mg/l @ 25 °C
  • 稳定性/保质期:
    Quinidine gluconate, quinidine polygalacturonate, and quinidine sulfate darken on exposure to light and should be stored in well-closed, light resistant containers. Solutions of quinidine salts slowly acquire a brownish tint on exposure to light. Only colorless, clear solutions of quinidine gluconate injection should be used. Quinidine gluconate injection should be stored at 15-30 °C. When diluted to a concentration of 16 mg/ml with 5% dextrose injection, quinidine gluconate injection is stable for 24 hours at room temperature and up to 48 hours when refrigerated. /Quinidine salts/
  • 旋光度:
    Specific optical rotation @ 15 °C/D + 230 deg (concn by volume = 1.8 in chloroform); specific optical rotation @ 17 °C/D + 258 deg (alcohol); +322 deg (concn by volume = 1.6 in 2 M HCl); UV absorption spectrum is identical with that of quinine; blue fluorescence in dilute H2SO4.
  • 分解:
    When heated to decomposition it emits toxic fumes of oxides of nitrogen.
  • 解离常数:
    pK1 @ 20 °C = 5.4; pK2 = 10.0

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    45.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
    申请人:Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    公开号:US06339091B1
    公开(公告)日:2002-01-15
    The compound of the formula wherein the substituents are defined as in the specification and its non-toxic, pharmaceutically acceptable salts which are useful for the treatment of viral infections, parasitic diseases and the treatment of cancer.
    该化合物的结构如下所示,其中取代基的定义如规范中所述,以及其无毒、药用可接受的盐,可用于治疗病毒感染、寄生虫病和癌症的治疗。
  • General method for iron-catalyzed multicomponent radical cascades–cross-couplings
    作者:Lei Liu、Maria Camila Aguilera、Wes Lee、Cassandra R. Youshaw、Michael L. Neidig、Osvaldo Gutierrez
    DOI:10.1126/science.abj6005
    日期:2021.10.22
    addition to vinyl boronates) with Grignard reagents. Then, we extended the scope of these radical cascades by developing a general and broadly applicable Fe-catalyzed multicomponent annulation–cross-coupling protocol that engages a wide range of π-systems and permits the practical synthesis of cyclic fluorous compounds. Mechanistic studies are consistent with a bisarylated Fe(II) species being responsible
    过渡金属催化的交叉偶联反应是化学合成中应用最广泛的一些方法。然而,尽管铁 (Fe) 作为一种潜在的更便宜、更丰富、毒性更小的过渡金属催化剂具有显着优势,但其在多组分交叉偶联中的实际应用仍然很大程度上不成功。我们展示了 1,2-双(二环己基膦基)乙烷 Fe 催化的 α-硼基自由基(由选择性自由基加成到乙烯基硼酸盐产生)与格氏试剂的偶联。然后,我们通过开发一种通用且广泛适用的 Fe 催化多组分环化-交叉偶联方案扩展了这些自由基级联的范围,该方案涉及广泛的 π 系统并允许实际合成环状氟化合物。
  • Practical Syntheses of Chiral α-Amino Acids and Chiral Half-Esters by Kinetic Resolution of Urethane-Protected α-Amino Acid <i>N</i>-Carboxyanhydrides and Desymmetrization of Cyclic <i>meso</i>-Anhydrides with New Modified Cinchona Alkaloid Catalysts
    作者:Yutaka Ishii、Ryosuke Fujimoto、Masafumi Mikami、Satoshi Murakami、Yasushi Miki、Yoshiro Furukawa
    DOI:10.1021/op700023h
    日期:2007.5.1
    The large-scale applications of the kinetic resolution of urethane-protected α-amino acid N-carboxyanhydrides (UNCAs) and the desymmetrization of cyclic meso-anhydrides using modified cinchona alkaloids are described. These asymmetric reactions are effective organocatalytic methods for the synthesis of chiral α-amino acids 6 and chiral half-esters 2 on an industrial scale, because the organocatalyst
    描述了氨基甲酸酯保护的α-氨基酸N-羧基酐(UNCA)的动力学拆分的大规模应用和使用改性金鸡纳生物碱对环状内消旋酸酐的脱对称化。这些不对称反应是在工业规模上合成手性α-氨基酸6和手性半酯2的有效有机催化方法,因为有机催化剂的回收和产物纯化可以通过简单的萃取程序进行,而无需色谱纯化步骤。改性金鸡纳生物碱催化剂(DHQD)2 AQN和(DHQ)2正如邓和同事所报道的,AQN尚不容易获得,因此不适合工业规模的合成。制备了各种O-烷基化的奎尼丁和奎宁衍生物,并筛选了用醇动力学拆分苯丙氨酸UNCA的催化剂。发现容易制备的O-炔丙基奎尼丁(OPQD)和O-炔丙基奎尼丁(OPQ)是高度对映选择性和实用的催化剂。这些新的催化剂施加到的手性炔丙基甘氨酸的合成24和BAY10-8888 / PLD-118,关键中间体26,在工业规模上,通过UNCA的动力学拆分22和环状的desymmetrization内消旋-酸酐25。
  • Organocatalytic Asymmetric Formal [3 + 2] Cycloaddition with in Situ-Generated <i>N</i>-Carbamoyl Nitrones
    作者:Claudio Gioia、Francesco Fini、Andrea Mazzanti、Luca Bernardi、Alfredo Ricci
    DOI:10.1021/ja902458m
    日期:2009.7.22
    A novel organocatalytic formal [3 + 2] cycloaddition reaction with in situ generation of N-carbamoyl nitrones is presented. For the first time, N-Boc- and N-Cbz-protected isoxazolidines have been directly obtained as single diastereoisomers in generally high yields and enantiomeric excesses using mild reaction conditions and inexpensive, readily available Cinchona alkaloid quaternary ammonium salts
    提出了一种新的有机催化形式 [3 + 2] 环加成反应,原位生成 N-氨基甲酰基硝酮。首次使用温和的反应条件和廉价、易得的金鸡纳生物碱季铵盐作为催化剂,直接以单一非对映异构体形式获得 N-Boc 和 N-Cbz 保护的异恶唑烷,收率通常很高,对映体过量。产品的合成操作提供了非常有价值的构建块,例如游离异恶唑烷、N-Boc-1,3-氨基醇和游离 δ-内酰胺。这份报告代表了在不对称催化中使用 N-氨基甲酰基硝酮作为缺电子 1,3-偶极子和戊二酸作为新的偶极子的开创性工作。
  • [EN] NEW COMPOUND BASED ON CINCHONA ALKALOÏDS FOR USE IN ASYMMETRIC MICHAEL ADDITION<br/>[FR] NOUVEAU COMPOSÉ À BASE D'ALCALOÏDES DE QUINQUINA S'UTILISANT DANS UNE ADDITION DE MICHAEL ASYMÉTRIQUE
    申请人:UCB PHARMA SA
    公开号:WO2013189920A1
    公开(公告)日:2013-12-27
    The present invention relates to compound of formula (1) and its use as a catalyst in the asymmetric Michael addition reactions.
    本发明涉及式(1)的化合物及其在不对称Michael加成反应中作为催化剂的用途。
查看更多